Pavilion Publishing and Media Ltd
Blue Sky Offices Shoreham, 25 Cecil Pashley Way, Shoreham-by-Sea, West Sussex, BN43 5FF, UNITED KINGDOM
Tel: +44 (0)1273 434 943
Email: [email protected]
Prostate cancer is the second leading cause of cancer death in men in the western world. Castrate resistant prostate cancer (CRPC) occurs when hormone therapy fails to arrest the growth of prostate cancer; death due to prostate cancer is a result of CRPC. Chemotherapy is used in the treatment of CRPC and has shown improvement in quality of life and a modest survival benefit.
---------------------------
This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.
Comments are closed.